Amends the Harmonized Tariff Schedule of the United States to: (1) reduce the current duty on pharmaceutical grade phospholipids; and (2) grant them, as well as pharmaceutical grade soybean oil, duty-free treatment if pharmaceutical products are granted duty-free status by an agreement which enters into force and effect with respect to the United States.
Introduced in House
Introduced in House
Sponsor introductory remarks on measure. (CR E314-315)
Referred to the House Committee on Ways and Means.
Referred to the Subcommittee on Trade.
Executive Comment Requested from Treasury, Commerce, ITC, USTR.
Executive Comment Received from ITC.
Llama 3.2 · runs locally in your browser
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line